
Formulary Search
You are here : Home > Formulary Search
Search Results : Weight management in adults (Tirzepatide - Weight management in adults)
Show Icon and Status Keys Hide Icon and Status Keys
Icon Key



Status Key
- Subcutaneous injection (sc)
Access in PRIMARY Care via a Locally Commissioned Service (which includes wrap around support) ONLY
BMI ≥ 40 kg/m2 (BMI should be adjusted by -2.5 kg/m² for individuals from ethnic backgrounds, AND at least FOUR of the five following comorbidities:
- Type 2 diabetes (T2DM), Hypertension, Dyslipidaemia, Cardiovascular disease (CVD), Obstructive sleep apnoea (OSA)
- Subcutaneous injection (sc)
Access through the specialist weight management service at Ashford & St Peters NHS Foundation Trust ONLY for patients in phase 1 here https://www.endocrinology.org/media/sjdpporx/joint-position-statement-on-medical-therapies-for-obesity_final-resubmitted-sfe-211223.pdf
After referral SWMS will consider appropriate initiation in line with cohort 1 here PRN01879-interim-commissioning-guidance-implementation-of-the-nice-technology-appraisal-ta1026-and-the-NICE-fu.pdf and will prescribe for 12 months prior to transfer of care.
- Capsules
- Subcutaneous injection (sc)
- Pre-filled pen
- Subcutaneous injection (sc)
- Not Specified